High-risk molecular features include Class 2 gene expression profile (GEP), expression of PRAME (preferentially expressed antigen in melanoma), BAP1 mutations leading to loss of BAP1 function, loss of heterozygosity on chromosome 3, and gain of chromosomes 1q, 6p, or 8q [5,6,7]. Here, BAP1 is linked to melanoma.